BackMarksans Pharma Limited Overview

Marksans Pharma Limited Profit Margin

Marksans Pharma Limited (MARKSANS.BO) has a profit margin of 16.51%, above the sector sector average of 13.4%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

15.03%
↑ 10.21% YoY

As of Sep 2026

Annual Profit Margin (TTM)

16.51%
↑ 28.17% YoY

Trailing 12 months ending Sep 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Marksans Pharma Limited (MARKSANS.BO) FAQ

The latest profit margin for MARKSANS.BO is 16.51% as of September 2026. That compares with 12.88% in the prior-year period — up 28.2% year over year. That is above the sector sector average of 13.4%. Investors often review this figure alongside Marksans Pharma Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, MARKSANS.BO's profit margin moved from 12.88% to 16.51% — a 28.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Marksans Pharma Limited's valuation or profitability profile.

Against its sector companies, MARKSANS.BO currently prints 16.51% for profit margin, while the sector average sits near 13.4%. That is roughly 23.1% above the sector mean. Large gaps often invite a closer look at Marksans Pharma Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Marksans Pharma Limited converts resources into returns. At 16.51%, MARKSANS.BO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 12.88% in the prior-year period — up 28.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting MARKSANS.BO's profit margin (16.51%), review year-over-year change from 12.88%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers